Viewing Study NCT05105295


Ignite Creation Date: 2025-12-24 @ 2:07 PM
Ignite Modification Date: 2025-12-27 @ 9:16 PM
Study NCT ID: NCT05105295
Status: UNKNOWN
Last Update Posted: 2021-11-03
First Post: 2021-10-22
Is Gene Therapy: True
Has Adverse Events: False

Brief Title: Immunogenicity and Safety of a Third Dose and Immune Persistence of BBIBP-Corv Vaccine in People With HIV Infected
Sponsor: China National Biotec Group Company Limited
Organization:

Study Modules

Identification Module Status Module Sponsor Collaborators Module Oversight Module Description Module Conditions Module Design Module Arms Interventions Module Outcomes Module Eligibility Module Contacts Locations Module